Back to results
US 2014/0348907 A1Published application
Methods and compositions involving mirna and mirna inhibitor molecules
AssigneeAsuragen, Inc.
InventorsDavid Brown, Lance Ford, Angie Cheng, Rich Jarvis, Mike Byrom, Dmitriy Ovcharenko, Eric Devroe, Kevin Kelnar
Life of this patent
Estimating the term…
Abstract
The present invention concerns methods and compositions for introducing miRNA activity or function into cells using synthetic nucleic acid molecules. Moreover, the present invention concerns methods and compositions for identifying miRNAs with specific cellular functions that are relevant to therapeutic, diagnostic, and prognostic applications wherein synthetic miRNAs and/or miRNA inhibitors are used in library screening assays.
Claims24
1-101. (canceled)
A pharmaceutical composition comprising a synthetic miR-126 molecule.
Dependencies are inferred from the claim text.